Two cases of chronic manganese poisoning were treated with sodium para-aminosalicylic acid (PAS-Na; 6 g/day in 500 ml of 10% glucose solution by intravenous drip). The results indicated that one had been clinically cured and that the other had obviously improved in clinical symptoms and signs. Thus PAS-Na appears to be an effective drug for treatment of serious chronic manganese poisoning.
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Our early studies suggest that PAS-Na is an effective drug in treating early manifestations of chronic manganese poisoning and causes increased urinary excretion of manganese.'2 Recently we applied PAS-Na to treat two cases of serious chronic manganese poisoning.
Case histories Case 1 was a 50 year old woman who had been occupationally exposed to manganese for 21 years . The range of manganese (MnO,) con- centration in the air of the workplace was 116-31-3 mg/m3.
The patient had suffered from palpitations and hand tremor since 1968 and had been misdiagnosed as having thyroidism. In 1980, she showed symptoms such as headache, giddiness, palpitation, salivation, failing memory, lower limb myalgia, myasthenia, and tetany and numbness in arms and legs. The patient often knelt down suddenly when walking. Physical examination at that time showed hands, tongue, and eyelids to be tremulous, rigidity or hypertonicity of muscles, a positive Houk's sign, and a positive nose pointing test. She had tremor while writing and a Table 1 The symptoms of two chronic serious manganese poisoning cases before and after being treated with PAS-Na and duringfollow up dragging gait. The patient was diagnosed as having chronic mild manganese poisoning by the occupational diseases diagnosis group (ODDG) in 1982 and admitted to hospital at the end of the year. After treatment with CaNa2 EDTA for expelling manganese over two courses, the symptoms were improved. These symptoms, however, returned and intensified in the first half of 1983. The patient had tingling in the muscles of extremities and aesthenia. Sometimes there was cramp in the limbs and pronounced trembling all over. She often went to the outpatient department of the hospital and was treated with Artane tablets, L-dopa, calcium gluconate, and several kinds of vitamins for a prolonged period. All the symptoms became worse. After admission to hospital for the second time in November 1984, her clinical symptoms and signs improved slightly and she was discharged after having taken CaNa2 EDTA for two courses combined with treatment with Ldopa and Artane tablets, energy mixture, and various vitamins. Six months later, however, the symptoms and signs emerged again and, became more aggravated daily. The patient had such symptoms as a tic at the angle of the lips and a bitten tongue while speaking, the upper extremities trembled greatly while writing and carrying. The body was unsteady when walking, and she had difficulty in coping with routine life. She was diagnosed as having chronic serious manganese poisoning by ODDG and was admitted to hospital for the third time in March 1987. Tables 1 and 2 show the symptoms and signs found on examination at admission. The pulse was 80/min, (fig 3) . Heart, lungs, and abdomen were normal. Chest x ray film showed that lung markings had increased slightly. The electrocardiogram and electroencephalogram were normal. Results of routine examination of blood, urine, and faeces were normal. Liver and renal function were also normal. Biochemical examination of urine disclosed that urinary manganese concentration was 2 21 Mg/24 h, 17-hydroxysteroid concentration was 2-6 mg/24 h, and 17-ketosteroid concentration was 10 14 mg/24 h.
The patient had ingested PAS-Na in tablet form for two weeks from 22 May, 1987, and the treatment had then been modified to 500 ml of 6 g PAS-Na added to 10% glucose solution given by intravenous drip. Tables 1 and 2 show the symptoms and signs at re-examination after treatment for three and a half months. He felt more "soft and comfortable." His speaking was clearer than before. His "mask-like" face had eased. He used a spoon well and his mouth no longer leaked food when eating. He walked faster than before, without help (taking one minute 20 seconds to cover 22 m) and was able to turn a corner slowly. His handwriting ability was evidently improved (see fig 4) . Results of various auxiliary examinations were grossly normal. The concentration of manganese in urine was 7-76 Mg/24 h during the treatment and 3 1 Mg/24 h after treatment. Values from other laboratory tests were not obviously changed. So he was discharged from hospital with evident improvement in his clinical symptoms and signs. Six months later follow up examination showed that the benefits were long term.
Discussion
Chronic manganese poisoning is regarded as an occupational disease that has no special treatment. It has been reported that metal chelating agents would increase manganese discharge from urine and improve clinical symptoms in some cases. In early cases of chronic manganese poisoning chelating agents were of conflicting benefit but did seem to produce some improvement in the condition if applied in its early phase when presumably neuronal destruction had not yet occurred. No improvement could be expected in those cases who had structural neurological lesions and extrapyramidal signs and symptoms.4 Poor results with CaNa2 EDTA in seven cases in the advanced phase but encouraging results only in one patient with early signs and symptoms was also reported.4 Treatment with EDTA was successful in two mild cases, but in three cases with more advanced neurological signs there was no improvement.4 Also EDTA applied to mild manganese poisoning for three to four treatment courses could improve 60% of cases, but gave no improvement in serious manganese poisoning with Parkinson's syndrome.3 It has been suggested that the late stage of serious managanese poisoning should not be treated with metal chelating agents, but with symptomatic treatment. Some anti-acetylcholine drugs such as Artane, K&madrine, and Scopolamine are used in symptomatic treatment in most cases. In the past few years, L-dopa and 5-hydroxy tryptophan have been used in chronic manganese poisoning with Parkinson's syndrome. During the course of treatment, the patient's muscular tension disorder was improved or disappeared but the original signs recurred soon after stopping drugs.
Our paper reports the application of PAS-Na in two cases of serious manganese poisoning. Case 1 had typical Parkinson's syndrome. She was admitted to hospital twice and took CaNa, EDTA to expel manganese, combined with other treatment. The results are similar to other reports.35 The patient received only PAS-Na treatment for three and a half months during her last stay in hospital. This time, her clinical symptoms and signs gradually improved and then disappeared. At follow up 19 months later no signs of relapse were found. It is 25 years since case 2 had been diagnosed as having chronic serious manganese poisoning with Parkinson's syndrome. After treatment with PAS-Na for three and a half months, his clinical symptoms and signs were improved.
Conclusion
Treatment with PAS-Na has been used effectively in the treatment of chronic serious managanese poisoning. But its mechanism is not clear and needs further study.
